Back to Search Start Over

Redox-responsive biocompatible nanocarriers based on novel heparosan polysaccharides for intracellular anticancer drug delivery

Authors :
Li Qin
Lu Ge
Huijie Zhang
Jinghua Chen
Jing Mao
Xiaotian Shan
Guozhong Lv
Kamel S. Ahmed
Lipeng Qiu
Miaomiao Long
Source :
Asian Journal of Pharmaceutical Sciences, Asian Journal of Pharmaceutical Sciences, Vol 15, Iss 1, Pp 83-94 (2020)
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Heparosan is a natural precursor of heparin biosynthesis in mammals. It is stable in blood circulation but can be degraded in lysosomes, showing good biocompatibility and long circulation features. So heparosan can be designed as anticancer drug carriers to increase tumor selectivity and improve the therapeutic effect. A novel redox-sensitive heparosan-cystamine-vitamin E succinate (KSV) micelle system was constructed for intracellular delivery of doxorubicin (DOX). Simultaneously, the redox-insensitive heparosan-adipic acid dihydrazide-vitamin E succinate copolymer (KV) was synthesized as control. DOX-loaded micelles (DOX/KSV) with an average particle size of 90–120 nm had good serum stability and redox-triggered depolymerization. In vitro drug release test showed that DOX/KSV micelles presented obvious redox-triggered release behavior compared with DOX/KV. Cytotoxicity and cell uptake were investigated using MGC80-3 tumor cells and COS7 fibroblast-like cells. The cell survival rate of blank micelles was more than 90%, and the cytotoxicity of DOX/KSV in MGC80-3 cells was higher than in COS7 cells, indicating that the carrier has better biocompatibility and less toxicity side effect. The cytotoxicity of DOX/KSV against MGC80-3 cells was significantly greater than that of free DOX and DOX/KV. Furthermore, compared with DOX/KV in MGC80-3 cells, DOX/KSV micelles uptook more anticancer drugs and then released DOX faster into the cell nucleus. The micelles were endocytosed by multiple pathways, but clathrin-mediated endocytosis was the main pathway. Therefore, heparosan polysaccharide could be a potential option as anticancer carrier for enhancing efficacy and mitigating toxicity.<br />Graphical abstract Redox-sensitive amphiphilic KSV copolymer was designed to deliver DOX. After passive targeted and uptaken by tumor cells, DOX was released rapidly into the nucleus in the intracellular reduced environment.Image, graphical abstract

Details

ISSN :
18180876
Volume :
15
Database :
OpenAIRE
Journal :
Asian Journal of Pharmaceutical Sciences
Accession number :
edsair.doi.dedup.....27b0a0eed5cab4bc23bf018e63ded729
Full Text :
https://doi.org/10.1016/j.ajps.2018.11.005